CASE STUDY: BUILDING A GLOBAL VACCINE SENTIMENT VIEW
Unlocking Global Vaccine Sentiment with a Bespoke Agentic AI Solution
CSL Seqirus operates as one of the largest providers of influenza vaccines in the world, manufacturing a diverse portfolio of differentiated seasonal and pandemic vaccines in addition to in‐licensed products in certain markets.
”“AMPLYFI’s AI solutions have empowered us to unlock vast sentiment trends with a depth and speed previously unimaginable. We are incredibly excited about the potential of AMPLYFI's insights to transform our research activities and inform our strategic decisions."
Josh Lee, Associate Director, Market Insights & Strategy, CSL Seqirus
Challenge
Traditional research methods, including consumer surveys, left gaps in CSL Seqirus’s understanding of global vaccine sentiment. They needed a more complete view that captured shifts in public opinion across different regions and demographics.
Working with AMPLYFI, the team set out to:
- Analyse vaccine sentiment across a wide range of global content, spanning news outlets, public media, and academic sources
- Detect emerging changes in perception across key markets
- Build a stronger foundation for strategic planning and market engagement
Solution
AMPLYFI’s Advanced Solutions team created a bespoke Agentic AI solution, purpose-built for CSL Seqirus to deliver a global sentiment analysis across vaccine technologies.
The project involved:
- Collecting and analysing approximately 130,000 documents from news, media, academic papers and public discussions
- Processing the equivalent of seven years’ human reading in under five minutes
- Running sentence-level sentiment analysis to identify key drivers across different age groups and regions
- Covering a global footprint including the United States, United Kingdom, and the EU
- The approach combined machine analysis with expert oversight, providing CSL Seqirus with a deeper, real-time understanding of how sentiment was evolving in both English and non-English sources
Impact
The new approach delivered immediate value:
- Early Trend Detection: Identified emerging patterns in sentiment before they became mainstream, helping the team act faster
- Sharper Research Focus: Insights from AMPLYFI are now feeding into future research design, making it more targeted and impactful
- Health Outcomes: By better understanding the drivers of vaccine sentiment, CSL Seqirus is supporting initiatives to boost vaccine uptake and improve public health
- Global Coverage: Captured public and academic perspectives across multiple languages and regions
By combining machine-led scale with expert-led refinement, the work demonstrated how bespoke Agentic AI solutions can go far beyond conventional research, especially when speed, depth and international coverage are required. The process took only a small fraction of the time and costs normally associated with an effort of this magnitude and allowed the group to deploy those resource savings in other meaningful investments.
